|
| |
Price : 5 slide for 600 €
| CT1 Human, thyroid cancer |
| |
|
|
|
|
|
|
| |
Age |
Sex |
Organ |
Diagnosis |
TNM |
Stage |
| 1 |
38 |
F |
thyroid |
papillary carcinoma |
T4N1aM0 |
Ⅰ |
| 2 |
43 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅰ |
| 3 |
31 |
F |
thyroid |
papillary carcinoma |
T4N1aM0 |
Ⅰ |
| 4 |
35 |
F |
thyroid |
papillary carcinoma |
T2NxM0 |
Ⅰ |
| 5 |
41 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅰ |
| 6 |
57 |
F |
thyroid |
papillary carcinoma |
T4NxM0 |
Ⅲ |
| 7 |
52 |
F |
thyroid |
papillary carcinoma |
T2N0M0 |
Ⅱ |
| 8 |
45 |
M |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅲ |
| 9 |
40 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅰ |
| 10 |
60 |
F |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅲ |
| 11 |
48 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅲ |
| 12 |
29 |
F |
thyroid |
papillary carcinoma |
T2N1M0 |
Ⅰ |
| 13 |
72 |
M |
thyroid |
papillary carcinoma |
T4N1bM0 |
Ⅲ |
| 14 |
24 |
M |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅰ |
| 15 |
37 |
F |
thyroid |
follicular carcinoma |
T2N0M0 |
Ⅰ |
| 16 |
56 |
F |
thyroid |
papillary carcinoma |
T4N1bM0 |
Ⅲ |
| 17 |
35 |
M |
thyroid |
follicular carcinoma |
T3N0M0 |
Ⅰ |
| 18 |
55 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅲ |
| 19 |
35 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅰ |
| 20 |
54 |
M |
neck |
papillary carcinoma |
T4N1M0 |
Ⅲ |
| 21 |
28 |
F |
thyroid |
papillary carcinoma |
T4N1aM0 |
Ⅰ |
| 22 |
45 |
F |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅲ |
| 23 |
46 |
M |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅲ |
| 24 |
36 |
F |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅰ |
| 25 |
67 |
F |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅲ |
| 26 |
22 |
F |
thyroid |
follicular carcinoma |
T2N0M0 |
Ⅰ |
| 27 |
45 |
M |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅲ |
| 28 |
33 |
F |
thyroid |
follicular carcinoma |
T2N0M0 |
Ⅰ |
| 29 |
36 |
F |
thyroid |
papillary carcinoma |
T2NxM0 |
Ⅰ |
| 30 |
21 |
F |
thyroid |
papillary carcinoma |
T2N0M0 |
Ⅰ |
| 31 |
22 |
F |
thyroid |
papillary carcinoma |
T4N1aM0 |
Ⅰ |
| 32 |
18 |
F |
thyroid |
papillary carcinoma |
T4N1aM0 |
Ⅰ |
| 33 |
17 |
F |
thyroid |
papillary carcinoma |
T2N0M0 |
Ⅰ |
| 34 |
51 |
F |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅲ |
| 35 |
50 |
F |
neck |
papillary carcinoma |
|
|
| 36 |
57 |
F |
thyroid |
follicular carcinoma |
T2N0M0 |
Ⅱ |
| 37 |
38 |
F |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅰ |
| 38 |
20 |
F |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅰ |
| 39 |
27 |
F |
thyroid |
follicular carcinoma |
T2N0M0 |
Ⅰ |
| 40 |
65 |
M |
thyroid |
follicular carcinoma |
T3N0M0 |
Ⅱ |
| 41 |
40 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅰ |
| 42 |
69 |
F |
thyroid |
papillary carcinoma |
T4N1aM0 |
Ⅲ |
| 43 |
50 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅲ |
| 44 |
51 |
M |
thyroid |
follicular carcinoma |
T2N0M0 |
Ⅱ |
| 45 |
53 |
M |
thyroid |
poorly differentiated carcinoma |
T4N0M0 |
Ⅳ |
| 46 |
47 |
M |
thyroid |
papillary carcinoma |
T4N1M0 |
Ⅲ |
| 47 |
63 |
M |
thyroid |
papillary carcinoma |
T2N0M0 |
Ⅱ |
| 48 |
58 |
M |
thyroid |
papillary carcinoma |
T3N0M0 |
Ⅱ |
| 49 |
75 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅲ |
| 50 |
15 |
F |
thyroid |
papillary carcinoma |
T4N0M0 |
Ⅰ |
| 51 |
45 |
M |
thyroid |
benign thyroid tissue (same patient of #8) |
T4N0M0 |
Ⅲ |
| 52 |
31 |
F |
thyroid |
benign thyroid tissue |
T4N0M0 |
Ⅰ |
| 53 |
38 |
F |
thyroid |
benign thyroid tissue |
T4N0M0 |
Ⅰ |
| 54 |
50 |
F |
thyroid |
benign thyroid tissue (same patient of #43) |
T4N0M0 |
Ⅲ |
| 55 |
52 |
M |
thyroid |
benign thyroid tissue |
T2N1M0 |
Ⅲ |
| 56 |
78 |
F |
thyroid |
benign thyroid tissue |
T2NxM1 |
Ⅳ |
| 57 |
32 |
F |
thyroid |
benign thyroid tissue |
T4N1M0 |
Ⅰ |
| 58 |
15 |
F |
thyroid |
benign thyroid tissue (same patient of #50) |
T4N0M0 |
Ⅰ |
| 59 |
37 |
F |
thyroid |
benign thyroid tissue |
T2N0M0 |
Ⅰ |
| 60 |
|
|
|
carbon particle |
|
|
| |
|
|
|
|
|
|
| TNM and stage classification:thyroid carcinoma(AJCC 5th Edition) |
|
|
General Information of the Tissue Array Slide :
Applications
- Immunohistochemistry
- In situ hybridization, RNA or DNA
- Fluorescent in situ hybridization (FISH)
- In situ PCR, RNA or DNA
- TUNEL for apoptosis (Recommended procedures in
www.tissue-array.com -> protocol)
Storage and stability
- Individual slide is paraffin-coated and put in an air-tight pack
with inert gas.
- Tissue array slides are shipped in room temperature.
- If the slides are stored in 4 degree, they are good up to one
year.
How processed
- Tissues were initially fixed with formalin except for some of the
animal tissues.
- Then, dehydrated with gradient ethanol; typically 1 hour each
progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
- Cleared by xylene, three changes for 1 hour each.
- Infiltrated with 60°C paraffin, three changes for 1 hour each
- Microtoming in 4 µm thickness and put on silane coating slide from
Muto Pure Chemicals (Japan)
Before use
- Dry slides for 1 hour in a oven at 60 degree.
- Dewax slides in xylene for 4 minutes x 5 times
- Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2
times each.
- Immerse slides in tap water for 5 minutes
Slide orientation
- In most of the slides with 59 or 60 cores, the orientation is as
below unless indicated otherwise. #60 location is usually filled with carbon
for orientation.
| 1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
| 11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
| 21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
| 31 |
32 |
33 |
34 |
35 |
36 |
37 |
38 |
39 |
40 |
| 41 |
42 |
43 |
44 |
45 |
46 |
47 |
48 |
49 |
50 |
| 51 |
52 |
53 |
54 |
55 |
56 |
57 |
58 |
59 |
60 |
|